AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%
Last update at 2024-12-19T18:51:00Z
Key Factors to Know Ahead of ARMOUR Residential REIT's Q3 Earnings
Mon 21 Oct 24, 02:16 PMAmerican Healthcare REIT (AHR) Moves to Strong Buy: Rationale Behind the Upgrade
Wed 25 Sep 24, 04:00 PM3 US Stocks Trading Up To 45.6% Below Intrinsic Value Estimates
Tue 24 Sep 24, 11:02 AMAmerican Healthcare REIT Announces Pricing of Upsized Primary Public Offering of Common Stock
Thu 19 Sep 24, 01:21 AMAmerican Healthcare REIT Announces Primary Public Offering of Common Stock
Wed 18 Sep 24, 08:03 PMTop 2 Real Estate Stocks That May Collapse This Month
Sun 15 Sep 24, 08:09 PMUS Exchange: American Healthcare REIT And 2 More Stocks Estimated Below Intrinsic Value
Mon 09 Sep 24, 11:07 AMAmerican Healthcare REIT Declares Third Quarter 2024 Distribution
Fri 06 Sep 24, 08:15 PMThese Two REITs Combined For 58% Gains In August: The Best Of The Month
Wed 04 Sep 24, 06:05 PM| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -76.22400M | 261.64M | 179.29M | 187.49M | -18.85900M |
| Minority interest | 5.42M | -7.91900M | 5.47M | -6.70000M | - |
| Net income | -71.46900M | -72.79700M | -52.31300M | 5.79M | -18.76900M |
| Selling general administrative | 47.51M | 43.42M | 43.20M | 27.01M | 29.75M |
| Selling and marketing expenses | 57.48M | - | - | 27.01M | - |
| Gross profit | 293.56M | -145.91000M | 81.10M | 119.54M | 18.48M |
| Reconciled depreciation | 237.30M | 200.60M | 157.38M | 129.65M | - |
| Ebit | 86.97M | -1519.37100M | -1051.10400M | -949.08600M | -1.13600M |
| Ebitda | 324.26M | 315.23M | 186.00M | 206.71M | 44.49M |
| Depreciation and amortization | 237.30M | 1834.60M | 1237.11M | 1155.80M | 45.63M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 244.34M | 450.47M | 133.19M | 98.86M | -1.13600M |
| Other operating expenses | 1613.09M | 1526.91M | 1228.36M | 1096.71M | 121.91M |
| Interest expense | 163.19M | 105.96M | 80.94M | 71.28M | - |
| Tax provision | 0.66M | 0.59M | 0.96M | -3.07800M | - |
| Interest income | - | - | - | - | - |
| Net interest income | -163.19100M | -105.95600M | -80.93700M | -71.27800M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.66M | -188.82800M | 46.10M | 88.63M | -0.00800M |
| Total revenue | 1859.14M | 1645.77M | 1283.21M | 1244.42M | 120.77M |
| Total operating expenses | 47.51M | 185.70M | 159.44M | 70.68M | 140.07M |
| Cost of revenue | 1565.58M | 1791.68M | 1202.11M | 1124.88M | 102.29M |
| Total other income expense net | -320.55900M | -163.38700M | -191.12200M | -125.78600M | -17.72300M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -76.88700M | -73.38300M | -53.26900M | 8.86M | - |
| Net income applicable to common shares | - | - | - | - | - |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 4577.93M | 539.22M | 1062.62M | 3234.94M | 1068.33M |
| Intangible assets | 180.47M | 236.28M | 248.87M | 154.69M | 160.25M |
| Earning assets | - | - | - | - | - |
| Other current assets | -0.20300M | -0.01300M | 2.83M | 55.60M | -28.47200M |
| Total liab | 3118.76M | 0.66M | 2.62M | 2160.11M | 476.79M |
| Total stockholder equity | 1270.32M | 4786.70M | 4580.34M | 866.11M | 590.08M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 529.43M | 965.06M | 305.60M | 126.85M | 883.02M |
| Common stock | 0.66M | 0.66M | 0.66M | 1.80M | 0.80M |
| Capital stock | 0.66M | 0.66M | 0.66M | - | - |
| Retained earnings | -1276.22200M | 1400.09M | 1581.29M | -864.27100M | -130.61300M |
| Other liab | - | - | - | - | - |
| Good will | 234.94M | 231.61M | 209.90M | 75.31M | 75.31M |
| Other assets | 80.74M | -4247.47400M | -3517.72200M | - | -2103.96200M |
| Cash | 43.45M | 111.91M | 125.49M | 152.19M | 15.85M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1466.87M | 16.30M | 21.16M | 194.68M | 173.72M |
| Current deferred revenue | -565.71600M | -5366.68000M | -4191.50800M | -3862.34900M | -779.82500M |
| Net debt | 2975.68M | -47.04800M | -67.95300M | 1724.71M | 420.08M |
| Short term debt | 846.77M | 316.73M | 921.90M | 1654.11M | 8.32M |
| Short long term debt | 1223.97M | 1281.79M | 1226.63M | - | - |
| Short long term debt total | 3019.12M | 64.86M | 57.53M | 1876.90M | 435.93M |
| Other stockholder equity | 2548.31M | 2540.42M | 2533.90M | 1730.59M | 722.15M |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 297.10M | 269.18M | 267.19M | 356.95M | 331.44M |
| Long term investments | 107.55M | 92.58M | 94.93M | - | - |
| Net tangible assets | - | - | - | - | - |
| Short term investments | 1.46M | - | - | - | - |
| Net receivables | 232.92M | 184.37M | 163.84M | 163.47M | 12.63M |
| Long term debt | 1344.15M | 1278.25M | 1129.25M | - | - |
| Inventory | 19.47M | 19.77M | 18.93M | 24.67M | 23.87M |
| Accounts payable | 90.67M | 243.83M | 187.25M | 67.83M | 62.20M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -2.42500M | 1649.36M | 1829.57M | -2.00800M | -2.25500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 3449.29M | -1105.99800M | -979.04900M | -883.25500M | 1429.82M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4200.09M | 4517.52M | 4313.15M | 2877.99M | 2840.85M |
| Capital lease obligations | 225.50M | 273.07M | 145.49M | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 9.40M | -118.57800M | -138.65200M | -147.94500M | - |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | - | - | - | - |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -129.06200M | -37.74100M | 102.81M | -19.71100M | 161.59M |
| Change to operating activities | - | - | - | - | - |
| Net income | -71.46900M | -81.30200M | -47.79400M | 2.16M | -18.76900M |
| Change in cash | -21.12400M | -13.58000M | -26.70400M | 136.34M | 1.26M |
| Begin period cash flow | 111.91M | 125.49M | 152.19M | 15.85M | 14.59M |
| End period cash flow | 90.78M | 111.91M | 125.49M | 152.19M | 15.85M |
| Total cash from operating activities | 98.53M | 147.77M | 15.20M | 210.12M | 40.83M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 182.60M | 450.47M | 133.19M | 98.86M | 45.63M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | 76.28M | 51.12M | 22.79M | 27.00M | 20.91M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -34.72400M | -4.45700M | 3.69M | 20.32M | 3.49M |
| Sale purchase of stock | -0.46900M | -20.69900M | -0.38200M | -23.10700M | -8.60900M |
| Other cashflows from financing activities | -34.72300M | -28.74600M | -20.33900M | -0.72400M | -0.15100M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 99.79M | 71.52M | 79.69M | 128.30M | 6.50M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -55.79000M | -37.79800M | -93.46700M | 74.19M | 6.63M |
| Stock based compensation | 5.47M | 3.91M | 9.66M | -1.18700M | 2.96M |
| Other non cash items | 37.72M | 707.92M | 325.68M | 176.85M | 91.88M |
| Free cash flow | -1.25600M | 76.25M | -64.49200M | 81.82M | 34.34M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHR American Healthcare REIT, Inc. |
0.12 0.44% | 27.50 | - | - | 2.15 | 1.98 | 3.18 | 19.84 |
| WELL Welltower Inc |
0.14 0.11% | 125.73 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
0.13 0.22% | 58.83 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
| OHI Omega Healthcare Investors Inc |
0.35 0.92% | 38.34 | 31.33 | 10.13 | 9.06 | 2.05 | 14.35 | 15.26 |
| HR Healthcare Realty Trust Incorporated |
0.02 0.12% | 16.92 | - | 10.83 | 4.82 | 0.93 | 8.92 | 15.95 |
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and other healthcare-related facilities. Its properties are located in 36 states, the United Kingdom and the Isle of Man.
18191 Von Karman Avenue, Irvine, CA, United States, 92612-7106
| Name | Title | Year Born |
|---|---|---|
| Mr. Danny Prosky | President, CEO & Director | 1964 |
| Mr. Brian S. Peay | Chief Financial Officer | 1966 |
| Mr. Gabriel M. Willhite | Chief Operating Officer | 1982 |
| Mr. Stefan K. L. Oh | Chief Investment Officer | 1971 |
| Mr. Mark E. Foster | Executive VP, General Counsel & Secretary | 1974 |
| Mr. Kenny Lin | Executive VP, Deputy CFO & Chief Accounting Officer | 1978 |
| Mr. Alan Robert Peterson III | Vice President of Investor Relations & Finance | NA |
| Ms. Cora Lo Esq., J.D. | Senior VP, Associate General Counsel & Assistant Secretary | 1975 |
| Ms. Wendie Newman | Executive Vice President of Asset Management | 1964 |
| Mr. Ray Oborn | Executive Vice President of Asset Management | 1971 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...